In recent years, SEO (search engine optimization) services have gained popularity and many SEO companies or agencies have cropped up to offer SEO services in Malaysia.
There are also outright scams from "bad apples" in the industry that had led you to be disappointed. The popularity of Google search engine optimization (SEO) and number one ranking is one of the primary selling features.
You should learn more about Google SEO from Google. Get direct updates and credible information directly from Google itself. Free resources such as Google Search Console, the official Webmaster Central blog, and Google’s discussion forum can provide you with a great deal of information about how to optimize your site for organic search.
Best SEO Companies in Selangor
The selection of the SEO companies below is based on Google Search Results and information available on blogs and forums. The top SEO companies in Malaysia have been arranged in no particular order. Here is the list.
1. Locus - T Online Sdn Bhd
Website : https://www.locus-t.com.my/
Facebook : https://www.facebook.com/locustMY/
Whatsapp : +6017-300 2078
Address: 72, Jalan 17/22, Seksyen 17, 47400 Petaling Jaya, Selangor
LOCUS-T is an Internet Marketing Agency, a company that is packed with 18 years of Internet Marketing experience.
Highlights
- Eligible for BSN SME Grant, up to 50% or up to RM5000 waiver
- Google SEO (Search Engine Optimization), Google Ads, Facebook Ads and Website Design
- Served over 7000 MNCs and SMEs
- Over 20 years experience in web development and web design
Testimonials
Locus-T helped position my company well on Google, and brought in 700% ROI during the first month.Besides the great results, their team is responsive and attentive to changes needed month by month. I would recommend them if you want your company to have a competitive online presence.
Address : C-20-05, Level 20, Colonial Loft, Empire City, Jalan PJU 8/1, Damansara Perdana, 47820, Petaling Jaya, Selangor
What sets this company apart is the clarity and comprehensiveness of the entire process. You can expect little to no failures in their strategies, which will be based around the structure and missions of your business. Their service will be tailor fit and extensive, providing both on-site optimisation as well as copywriting to help you get ahead of your competition.
Services : SEO, Google Ads, Facebook Ads, Website Development, Video Production, Copywriting
Testimonial
Kempen Facebook Ads kami dapat return yang lebih tinggi bila Bomstart Media yang handle. Masa buat sendiri kami hanya boleh dapat ROAS sekitar 5 sahaja. Bila Bomstart buat, dapat ROAS sehingga 20. Bomstart Media terbaik.. 👍👍👍
Address: A-06-07, Prima Avenue, Jalan PJU 1/39, Dataran Prima, 47301 Petaling Jaya, Selangor
"You’re reading this because you found us on Google. We compete with some of the top SEO service providers in the country and yet we still outranked them. Besides, if you are not ranked on Google, your competitors will be and they will the be the ones that reach out to your customers. SEO is no longer a nice to have, it is a must have for any business or company. Imagine waking up with customers contacting you for your products or services, all day, everyday. We know how that feels like and it is amazing."
Highlights
- Google Rankings or the bears will work for free : Free if you don't show up on page 1 of Google within 90 days
- Over 700 projects completed
Testimonial
I chanced upon Bike Bear when I was Google searching for a website design company. Being a marketer, I was very meticulous about the quality of work. I didn't want mere designers to do the job, no matter how great their aesthetic sense may be... I wanted people who understood how their design and website development can help propel my business goals.
1 and a half years later, I'm glad to say I have found a reliable and strong partner. Their design is not only great, they also took the effort to support our business goals through strategic website development and marketing campaigns.
Till this day, I still find it amusing that I found them through a Google Search. Needless to say, their SEO team must have done something right.
Really grateful to have Ariel, Jason and their excellent team seeing us through numerous websites and marketing campaigns. Hey, they even won us an award through our official website.
As we enter 2026, the memory and storage crunch predicted in late 2025 has materialized with even greater intensity. AI data centers continue to dominate global production of DRAM and NAND flash, pushing prices sharply higher and extending lead times across consumer, PC, and enterprise segments. Nearly every analyst firm and memory maker is now warning of looming NAND and DRAM shortages that will send SSD and memory prices skyrocketing over the coming months and years, with some even predicting a shortage that will last a decade. For the better part of two years, storage upgrades have been a rare bright spot for PC builders. SSD prices cratered to all-time lows in 2023 , with high-performance NVMe drives selling for little more than the cost of a modest mechanical hard disk. DRAM followed a similar trajectory, dropping to price points not seen in nearly a decade. In 2024, the pendulum swung firmly in the other direction, with prices for both NAND flash and DRAM sta...
The correlation between the Nasdaq index and cryptocurrencies, particularly Bitcoin, has been a subject of interest and analysis, reflecting the increasing integration of digital assets into the broader financial ecosystem. Updated Status as of November 2025 The core thesis from the original article remains valid: Bitcoin continues to behave like a high-beta tech asset with a strong positive correlation to the Nasdaq 100. However, the relationship has evolved with some important nuances in 2025. 30-day rolling correlation (BTC vs. Nasdaq 100) : ~0.80 → Highest level since 2022 and the second-highest in the past decade (sources: Kobeissi Letter, Wintermute, CoinDesk) 5-year average correlation : ~0.54 → Confirms the recent spike is part of a longer-term uptrend that began in 2020 Year-to-date performance (Jan 1 – Nov 20, 2025) : → Nasdaq 100: +20% → Bitcoin: +3–4% → BTC has significantly underperformed tech stocks despite the tight correlation Key new phenomenon in 2025 : Strong negativ...
Table of Contents: Largest Pharma Companies by Revenue (Global Ranking) Top 10 Pharmaceutical Companies by Market Cap in 2025 Top 10 Most Anticipated Drug Launches of 2025 Top 10 Drugs Losing US Exclusivity in 2025 The largest pharma companies in the world play a central role in global healthcare, developing blockbuster drugs for cancer, cardiovascular disease, immunology, vaccines, and metabolic disorders. In 2025, the biggest pharmaceutical companies by revenue continued to dominate through scale, research spending, and global distribution—despite growing pressure from patent expirations, biosimilars, and pricing reforms. Medical stocks are releasing earnings reports in droves. Eli Lilly and Co (LLY.US) targets $80 billion in 2026 revenue with standout performance; Novo-Nordisk A/S (NVO.US) beats Q4 expectations but lowers 2026 guidance due to pricing pressures. The largest pharma companies are defined not only by revenue, but by global scale, research investment, and thera...
The ten largest food and beverage companies in the world remain Nestle, Ahold Delhaize, PepsiCo., Archer Daniels Midland, Sysco, JBS, Performance Food Group, Anheuser-Busch InBev, Unilever, and Tyson Foods. The global food and beverage industry remains one of the largest and most resilient sectors of the world economy, generating trillions of dollars in annual revenue . While consumer preferences, inflation, and supply-chain realignments continue to reshape the market, a relatively small group of multinational corporations still dominate global food sales. This January 2026 update revises our original 2025 rankings using the latest available full-year 2024 results, 2025 trailing-twelve-month (TTM) data, and confirmed late-2025 corporate developments , including major mergers, recalls, and strategic restructurings. Top 10 Food Companies by Revenue This ranking reflects the largest companies primarily by annual revenue, emphasizing food production, processing, distri...
As 2025 draws to a close, the fusion of artificial intelligence (AI) and robotics continues to redefine industries from manufacturing to healthcare. What began as a speculative tech boom has matured into tangible productivity gains, with global robotics market projections soaring from $94 billion in 2024 to potentially $373 billion by 2034. AI's role in enabling smarter automation—think humanoid robots in warehouses or surgical systems in operating rooms—positions these technologies as the backbone of the next industrial revolution. For investors eyeing 2026, exchange-traded funds (ETFs) offer a diversified gateway to this high-growth sector without the pitfalls of stock-picking volatility. Yet, the landscape isn't without challenges. Recent market jitters around AI hype have led to underperformance in some funds, but experts like Fidelity's Adam Benjamin highlight AI's "far-reaching" disruption potential, with capex from tech giants like Amazon and Microsoft ...
After its outsized gains in 2024–2025, silver experienced a sharp pullback entering February 2026 — a move that surprised many late-cycle buyers but was consistent with historical silver bull markets. This correction was driven by several overlapping factors: Profit-taking after extreme gains , particularly in leveraged and mining-linked products A stronger U.S. dollar and shifting rate expectations , which temporarily pressured precious metals Speculative positioning unwinds , as futures and options markets became crowded Equity market rotation , drawing capital back toward risk assets Importantly, the pullback did not coincide with a collapse in industrial demand or a sudden resolution of supply constraints. As a result, many analysts view the move as a volatility reset rather th...
As February 2026 begins, investors face a market defined by high valuations, persistent inflation risk, geopolitical uncertainty, and increasingly narrow equity leadership . The easy-money era is gone, but long-term opportunities remain — if ETFs are chosen for structure, not speculation . This list highlights the best ETFs to buy in February 2026, grouped by portfolio role, not hype. The goal is resilience, diversification, and intelligent exposure to themes that matter this year. How These ETFs Were Selected Each ETF was evaluated based on: Long-term performance and liquidity Expense ratio and fund structure Relevance to current macro conditions Usefulness within a diversified portfolio This is not a short-term trading list. These ETFs are best suited for investors with a multi-year horizon . Core Market ETFs (Foundation Holdings) These ETFs form the backbone of most long-term portfolios. 1. Vanguard S&P 500 ETF (VOO) Best for: Core U.S. equity exposure VOO remains one of the m...
The pharmaceutical market in 2025 continues to be led by innovative therapies addressing cancer, metabolic diseases, autoimmune conditions, and chronic illnesses. Below is an updated overview of the top 10 drugs by projected global sales in 2025. Summary 1. Keytruda (Merck): 31B 2. Ozempic (Novo Nordisk): 21 B 3. Mounjaro (ELi Lilly): 19 B 4. Dupixent (Sanofi and Regeneron): 17 B 5. Wegovy (Novo Nordisk): 14 B 6. Biktarvy (Gilead Sciences): 13.4 B 7. Skyrizi (Abbvie): 13 B 8. Eliquis (Bristol-Myers Squibb): 13 B 9. Darzalex (Johnson & Johnson): 13 B 10. Humira (Abbvie): 12.5 B Highlights and Market Trends Keytruda (Pembrolizumab) remains the global leader in drug sales with projected revenues exceeding $31 billion in 2025. This cancer immunotherapy has expanded to over 40 approved indications since its launch in 2014, including multiple cancer types, driving strong sales growth. Merck reported $21.6 billion in sales for the first three quarters of 2024, an 18% increase year-on-year...
As AI video generation tools like Stable Video Diffusion, Runway ML, and emerging models from OpenAI continue to evolve, having the right GPU is crucial for creators, developers, and enthusiasts. In 2026, AI video workflows demand high VRAM for handling large models, efficient tensor cores for acceleration, and robust support for frameworks like PyTorch and TensorFlow. NVIDIA remains the leader due to its CUDA ecosystem, but AMD offers competitive alternatives with improving ROCm support. This guide ranks the best GPUs based on performance, VRAM, power efficiency, and value for AI video tasks such as text-to-video, video upscaling, and style transfer. Key Factors to Consider When Choosing a GPU for AI Video Generation Before diving into recommendations, here's what matters most in 2026: VRAM Capacity : Aim for at least 24GB to run high-resolution models without batching or offloading. Architecture : NVIDIA's Blackwell (RTX 50-series) offers multi-frame generation (MFG) for fast...
The pharmaceutical sector continues to thrive in 2025, driven by breakthroughs in biotechnology, rising demand for innovative treatments, and a global push toward personalized medicine. With an aging population and increasing healthcare spending projected to reach $10 trillion worldwide by 2026, investing in pharma offers a compelling opportunity for long-term growth. Exchange-traded funds (ETFs) focused on pharmaceuticals provide diversified exposure to leading drug makers, reducing the risk of picking individual stocks like Eli Lilly (LLY) or Johnson & Johnson (JNJ). In this guide, we'll explore the top pharma ETFs for 2025, ranked by assets under management (AUM), year-to-date (YTD) performance, and overall appeal for investors seeking stability and upside in healthcare. Whether you're a beginner eyeing low-cost options or a seasoned trader chasing high-growth biotech plays, these best pharmaceutical ETFs can anchor your portfolio. All data is current as of mid-November ...
Comments